Home » Newsletters » BioWorld Science

BioWorld Science

April 29, 2003

View Archived Issues

Targeted Genetics and Cystic Fibrosis Foundation Therapeutics collaborate on tgAAV-CF

NIH offers licenses to new chondropsin V-ATPase inhibitor

Effective back and leg pain alleviation reported with infliximab in sciatica

Donepezil plus conventional neuroleptics effective for psychotic symptoms in AD

Tadalafil confirmed to be effective and well tolerated in patients with erectile dysfunction

A potential new indication described for mycophenolate mofetil

Greater benefits found for sildenafil plus sertraline in premature ejaculation

Antitumor efficacy reported for a novel monoclonal antibody in advanced renal cell carcinoma

Highly potent Pfs inhibitors identified at Quorex as potential broad-spectrum antimicrobials

Testosterone gel restores physiological serum levels of testosterone in hypogonadal men

BMS researchers design novel chemokine CCR3 receptor modulators

SCI-induced bladder hyperreflexia improved by NK2 receptor antagonists

New cathepsin inhibitors with utility in osteoporosis therapy reported by Celera

New CXCR2 antagonists and their use in rheumatoid arthritis and COPD

Zeria researchers present new H+/K+-ATPase inhibitors

Novel 5-HT receptor modulators in early development at Pharmacia

Macrocyclic antibacterial agents prepared and tested at Bayer

Indole-based prostanoid DP receptor antagonists newly discovered at Ono

Merck scientists isolate a novel HIV integrase inhibitor from Cytospora cultures

Another series of alpha2/alpha3-selective GABA-A modulators reported by Merck

Celgene discusses progress during the first quarter

First-quarter highlights at Tularik

Nippon Boehringer Ingelheim and Sankyo intend to comarket Alesion

MedImmune postpones MEDI-507 trials in psoriasis

GenVec and NIAID to develop SARS vaccine

Search for SARS treatment at Medarex and MBL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....